Haemostatic parameters and vascular risk

被引:24
作者
JuhanVague, I
机构
关键词
cardiovascular risk; fibrinogen; factor VII; plasminogen activator inhibitor (PAI-1); tissue plasminogen activator (tPA); genetic and environmental determinants;
D O I
10.1016/0021-9150(96)05857-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Associations between increased plasma concentrations of the three haemostatic factors - fibrinogen, Factor VII and plasminogen activator inhibitor 1 (PAI-1) - and cardiovascular disease (CVD) have recently been demonstrated in epidemiological studies. The relative risk of CVD is increased by 2-3 times in subjects whose levels of fibrinogen fall within the upper third of the general distribution in comparison to those subjects who fall into the lower third; a positive correlation exists between increased Factor VII activity and cardiovascular mortality. Many studies have demonstrated that elevated levels of PAI-1 and tPA antigen are associated with CVD. Several studies have also shown that there are important associations between conventional risk factors for atherothrombosis and haemostatic factors. Fibrinogen levels are strongly linked with smoking, and Factor VII levels are linked with cholesterol, triglycerides and fat intake. PAI-1 and tPA antigen levels, on the other hand, are closely associated with insulin resistance. This paper discusses the principal genetic and environmental determinants of the plasma levels of each of these three haemostatic factors and relates them to the risk of developing CVD.
引用
收藏
页码:S49 / S55
页数:7
相关论文
共 63 条
[1]   CORRELATIONS BETWEEN T-PA AND PAI-1 ANTIGEN AND ACTIVITY AND T-PA/PAI-1 COMPLEXES IN PLASMA OF CONTROL SUBJECTS AND OF PATIENTS WITH INCREASED T-PA OR PAI-1 LEVELS [J].
ALESSI, MC ;
JUHANVAGUE, I ;
DECLERCK, PJ ;
ANFOSSO, F ;
GUEUNOUN, E ;
COLLEN, D .
THROMBOSIS RESEARCH, 1990, 60 (06) :509-516
[2]  
BALLEISEN L, 1985, THROMB HAEMOSTASIS, V54, P475
[3]   RELATION OF FETAL AND INFANT GROWTH TO PLASMA-FIBRINOGEN AND FACTOR-VII CONCENTRATIONS IN ADULT LIFE [J].
BARKER, DJP ;
MEADE, TW ;
FALL, CHD ;
LEE, A ;
OSMOND, C ;
PHIPPS, K ;
STIRLING, Y .
BMJ-BRITISH MEDICAL JOURNAL, 1992, 304 (6820) :148-152
[4]   IDENTIFICATION AND DISTRIBUTION OF FIBRINOGEN, FIBRIN, AND FIBRIN(OGEN) DEGRADATION PRODUCTS IN ATHEROSCLEROSIS - USE OF MONOCLONAL-ANTIBODIES [J].
BINI, A ;
FENOGLIO, JJ ;
MESATEJADA, R ;
KUDRYK, B ;
KAPLAN, KL .
ARTERIOSCLEROSIS, 1989, 9 (01) :109-121
[5]   PLASMINOGEN-ACTIVATOR INHIBITOR-1 GENE DEFICIENT MICE .2. EFFECTS ON HEMOSTASIS, THROMBOSIS, AND THROMBOLYSIS [J].
CARMELIET, P ;
STASSEN, JM ;
SCHOONJANS, L ;
REAM, B ;
VANDENOORD, JJ ;
DEMOL, M ;
MULLIGAN, RC ;
COLLEN, D .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (06) :2756-2760
[6]   FIBRINOLYTIC-ACTIVITY AND ISCHEMIC-HEART-DISEASE [J].
CORTELLARO, M ;
COFRANCESCO, E ;
BOSCHETTI, C .
LANCET, 1993, 342 (8885) :1489-1489
[7]   INCREASED FIBRIN TURNOVER AND HIGH PAI-1 ACTIVITY AS PREDICTORS OF ISCHEMIC EVENTS IN ATHEROSCLEROTIC PATIENTS - A CASE-CONTROL STUDY [J].
CORTELLARO, M ;
COFRANCESCO, E ;
BOSCHETTI, C ;
MUSSONI, L ;
DONATI, MB ;
CARDILLO, M ;
CATALANO, M ;
GABRIELLI, L ;
LOMBARDI, B ;
SPECCHIA, G ;
TAVAZZI, L ;
TREMOLI, E ;
POZZOLI, E ;
TURRI, M ;
CORTELLARO, M ;
COFRANCESCO, E ;
BOSCHETTI, C ;
CARDILLO, M ;
TORRI, M ;
RAINISIO, M ;
GENTILE, G ;
MOREO, G ;
BIANCHI, O ;
LEONARDI, P ;
COLOMBI, M ;
CATALANO, M ;
GALIMBERTI, P ;
RUSSO, U ;
CRESSOTTI, A ;
CARZANIGA, G ;
NOBILI, S ;
NINNO, D ;
DONATI, MB ;
IACOVIELLO, L ;
DEGAETANO, G ;
GABRIELLI, L ;
MARTELLI, E ;
CORSI, G ;
LORENZI, G ;
LOMBARDI, B ;
CARRIERO, MR ;
COLOMBO, R ;
SPECCHIA, G ;
CIOFFI, P ;
SCIRE, A ;
TAVAZZI, L ;
GIANNUZZI, P ;
CORRA, U ;
TEMPORELLI, L ;
MORA, F .
ARTERIOSCLEROSIS AND THROMBOSIS, 1993, 13 (10) :1412-1417
[8]  
CREMER P, 1992, DIAGNOSE LABOR, V42, P28
[9]   THROMBOSIS AND ACUTE CORONARY-ARTERY LESIONS IN SUDDEN CARDIAC ISCHEMIC DEATH [J].
DAVIES, MJ ;
THOMAS, A .
NEW ENGLAND JOURNAL OF MEDICINE, 1984, 310 (18) :1137-1140
[10]   GENETIC-VARIATION AT THE PLASMINOGEN-ACTIVATOR INHIBITOR-1 LOCUS IS ASSOCIATED WITH ALTERED LEVELS OF PLASMA PLASMINOGEN-ACTIVATOR INHIBITOR-1 ACTIVITY [J].
DAWSON, S ;
HAMSTEN, A ;
WIMAN, B ;
HENNEY, A ;
HUMPHRIES, S .
ARTERIOSCLEROSIS AND THROMBOSIS, 1991, 11 (01) :183-190